A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
Crossref DOI link: https://doi.org/10.1186/s13104-015-1778-4
Published Online: 2016-03-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Graham, J. S.
Boyd, K.
Coxon, F. Y.
Wall, L. R.
Eatock, M. M.
Maughan, T. S.
Highley, M.
Soulis, E.
Harden, S.
Bützberger-Zimmerli, P.
Evans, T. R. J.